Michael K. McGarrity - CEO
Mr. McGarrity then joined Nanosphere Incorporated, a nanotechnology based molecular diagnostics company, where he took over as CEO in February of 2013 and engineered a turnaround of the company resulting in a successful sale of the company to Luminex in 2016. Mr. McGarrity is a graduate of the University of Notre Dame and began his career in commercial banking in Chicago.
Jeffrey H. Bell
Jeffrey H. Bell founded the Company in June 2011 and serves as President, Chief Financial Officer and Chairman of the Board of Directors. Prior to founding Sterilis, Mr. Bell acted as Chief Operating Officer of an Australian listed medical device company, Norwood Abbey Limited. During this time Mr. Bell was directly involved or responsible for:
- Capital raise – over $100M raised through various equity debt and quasi debt securities.
- Licensing – responsible for both in-license and out-license agreements for a variety of medical device technologies.
- Mergers & Acquisitions – negotiated and closed the successful purchase of an ophthalmic product line from Novartis subsidiary CIBA Vision.
- Spin out of subsidiary technology on the London Stock Exchange achieving a tenfold increase in book value upon listing.
Prior to joining Norwood, Mr. Bell worked as a Chartered Accountant for ten years and is an associate member of the Institute of Chartered Accountants in Australia.Mr. Bell has held various Board and Company Secretarial positions in both public and private companies.